Interleukin-1 receptor associated kinase 1/4 and bromodomain and extraterminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88L265P mutation.

Like Comment
Not available.

View the full article @ Haematologica

Get PDF with LibKey
Authors: Ivan Dlouhy, Marc Armengol, Clara Recasens-Zorzo, Marcelo L Ribeiro, Patricia Pérez-Galán, Francesc Bosch, Armando López-Guillermo, Gaël Roué


The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
6584 Contributions
0 Following